Inter Pharma Public Company Limited PEG Ratio

Inter Pharma Public Company Limited's peg ratio stands at 123.32. That is above the Healthcare sector average of 27.75. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Inter Pharma Public Company Limited sits higher the Healthcare benchmark (27.75) with a PEG ratio of 123.32. That is roughly 344.4% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 123.32 is attractive depends on Inter Pharma Public Company Limited's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Inter Pharma Public Company Limited's PEG ratio evolved across reporting periods, while the comparison chart places IP.BK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Inter Pharma Public Company Limited's reading of 123.32 (sector avg 27.75) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.